Abstract 2128P
Background
Exercise (EX) is associated with a reduction in mortality and recurrence risk in patients (pts) with cancer and may help pts cope with treatment side effects and improve their quality of life. This study aims to explore the role of oncologists in promoting exercise in the oncological context.
Methods
A self-administered, anonymous questionnaire was proposed to pts visiting the outpatients’ facilities at the Oncology Unit of Verona Hospital. The questionnaire assessed demographic, health, and EX parameters. EX variables, drawn from a prior study, included: the level evaluated with Godin’s Leisure Time Exercise Questionnaire and information regarding: whether EX was discussed; whether oncologists assess, advise, reinforce, and refer (AARR process) pts effort to exercising; and whether pts preferred that EX be discussed. Descriptive statistic, presented as mean, frequencies, and percentages, was applied.
Results
Overall, 202 pts completed the survey (76% response rate). The most frequent tumor types were upper gastrointestinal (45%) and breast (19%). Only 9% of pts were sufficiently active. Regarding the actual EX discussion, 29% of pts reported that their oncologist started a discussion about EX, 12% initiated the discussion themselves, and 60% referred that the issue was not considered. Concerning the AARR process, 26% of pts declared that their oncologists assessed their EX level, 14% and 33% received advice or reinforcement to increase their EX, respectively, and 9% were referred to an appropriate EX service. On the other hand, the items related to the preferred modality of EX discussion showed that 69% of pts thought that oncologists should initiate an EX-discussion, 3% that only pts should start the discussion, and 23% thought that EX should not be discussed.
Conclusions
Our preliminary results show that most pts are insufficiently active, and the majority stated that they did not discuss EX. Nevertheless, most pts would prefer that oncologists initiate a discussion about EX. According to these findings, strategies to support clinicians in promoting EX to their pts should be developed. Further pts’ enrollment is currently ongoing and a more updated analysis will be available for presentation at the ESMO Congress.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2045P - Patient Reported Outcome Measures (PROMs) capturing therapy adherence of cancer patients: A systematic literature review
Presenter: Luise Richter
Session: Poster session 06
2046P - The importance of communicating bad news in medical education
Presenter: Georgios Goumas
Session: Poster session 06
2047P - Neutrop: A descriptive, observational study for G-CSF prescription in daily practice
Presenter: Florian Scotté
Session: Poster session 06
2048P - Frequency and clinical relevance of drug-drug interactions with oxycodone among patients with cancer
Presenter: Lotte Hulskotte
Session: Poster session 06
2049P - Osimertinib-related muscle cramps as a common adverse event: A real-world data analysis in the post-approval setting
Presenter: Gisele Moreira
Session: Poster session 06
2050P - Integrating ayurveda herbs with standard of care for management of cancer or cancer treatment related anorexia
Presenter: Yogesh Bendale
Session: Poster session 06
2051P - E-PRO within comprehensive companion program for patients undergoing systemic cancer treatment to reduce emergency visits and inpatient admission in a Peruvian institution
Presenter: Patricia Rioja Viera
Session: Poster session 06
2052P - Adverse events in FLOT chemotherapy for locally advanced gastric cancer: An observational study of pre- and post-operative toxicity profiles
Presenter: Camila Oliveira
Session: Poster session 06
2053P - Dehospitalization through outpatient drug release in clinical pharmacy as a strategic cost-minimization action in a public oncology hospital in the Eastern Amazon: A quantitative analysis
Presenter: Kalysta Borges
Session: Poster session 06
2054P - Metastatic cancer patients hospitalized at initial diagnosis: When does rescue systemic therapy make sense? ONIRIS - A national, prospective study
Presenter: Colin Vercueil
Session: Poster session 06